Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Single Arm Study of Neoadjuvant Dostarlimab (TSR-042) in Stage II and III Deficient Mismatch Repair Colon Cancers

NCT05239546 is registered in ClinicalTrials.gov with University of Iowa as lead sponsor.

NCT NCT05239546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05239546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Single Arm Study of Neoadjuvant Dostarlimab (TSR-042) in Stage II and III Deficient Mismatch Repair Colon Cancers
Lead sponsor
University of Iowa
Phase
Phase 2
Overall status
Recruiting
Start date
March 24, 2023
Completion date
June 30, 2029
Enrollment
25 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, dmmr colorectal cancer